The clinical and radiological parameters utilized in this study were derived from our clinical experience, since current treatment decision algorithms are based on standard clinicopathologic prognostic, and predictive factors, large datasets using clinical measures such as tumor size, node status, grade, ER, and HER2-neu [9,10,59,60,61,62,63]. The gene discussed is ERBB2; the disease is neoplasm.